616 related articles for article (PubMed ID: 17084803)
21. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
Aleman TS; Cideciyan AV; Windsor EA; Schwartz SB; Swider M; Chico JD; Sumaroka A; Pantelyat AY; Duncan KG; Gardner LM; Emmons JM; Steinberg JD; Stone EM; Jacobson SG
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1319-29. PubMed ID: 17325179
[TBL] [Abstract][Full Text] [Related]
22. Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density.
Berendschot TT; Plat J; de Jong A; Mensink RP
Br J Nutr; 2009 Jun; 101(11):1607-10. PubMed ID: 18986598
[TBL] [Abstract][Full Text] [Related]
23. Dietary modification of human macular pigment density.
Hammond BR; Johnson EJ; Russell RM; Krinsky NI; Yeum KJ; Edwards RB; Snodderly DM
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1795-801. PubMed ID: 9286268
[TBL] [Abstract][Full Text] [Related]
24. Macular pigment optical density and photophobia light threshold.
Wenzel AJ; Fuld K; Stringham JM; Curran-Celentano J
Vision Res; 2006 Dec; 46(28):4615-22. PubMed ID: 17087988
[TBL] [Abstract][Full Text] [Related]
25. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study.
Koh HH; Murray IJ; Nolan D; Carden D; Feather J; Beatty S
Exp Eye Res; 2004 Jul; 79(1):21-7. PubMed ID: 15183097
[TBL] [Abstract][Full Text] [Related]
26. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Ma L; Dou HL; Huang YM; Lu XR; Xu XR; Qian F; Zou ZY; Pang HL; Dong PC; Xiao X; Wang X; Sun TT; Lin XM
Am J Ophthalmol; 2012 Oct; 154(4):625-634.e1. PubMed ID: 22835510
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
[TBL] [Abstract][Full Text] [Related]
29. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail.
Toyoda Y; Thomson LR; Langner A; Craft NE; Garnett KM; Nichols CR; Cheng KM; Dorey CK
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1210-21. PubMed ID: 11923268
[TBL] [Abstract][Full Text] [Related]
30. The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers.
Graydon R; Hogg RE; Chakravarthy U; Young IS; Woodside JV
Br J Nutr; 2012 Jul; 108(2):334-42. PubMed ID: 22313522
[TBL] [Abstract][Full Text] [Related]
31. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
32. Macular pigment and visual performance under glare conditions.
Stringham JM; Hammond BR
Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
[TBL] [Abstract][Full Text] [Related]
33. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
[TBL] [Abstract][Full Text] [Related]
34. Lutein and zeaxanthin in the eyes, serum and diet of human subjects.
Bone RA; Landrum JT; Dixon Z; Chen Y; Llerena CM
Exp Eye Res; 2000 Sep; 71(3):239-45. PubMed ID: 10973733
[TBL] [Abstract][Full Text] [Related]
35. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Nolan JM; Stack J; O'connell E; Beatty S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
[TBL] [Abstract][Full Text] [Related]
36. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
37. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome.
Aleman TS; Duncan JL; Bieber ML; de Castro E; Marks DA; Gardner LM; Steinberg JD; Cideciyan AV; Maguire MG; Jacobson SG
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1873-81. PubMed ID: 11431456
[TBL] [Abstract][Full Text] [Related]
38. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
Dietzel M; Zeimer M; Heimes B; Claes B; Pauleikhoff D; Hense HW
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3452-7. PubMed ID: 21296816
[TBL] [Abstract][Full Text] [Related]
39. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
[TBL] [Abstract][Full Text] [Related]
40. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
